DuPont de Nemours, Inc. · NYSE:DD

DuPont de Nemours — DuPont — Technical Presentation (May 2015)

38 slides from DuPont de Nemours's technical presentation, May 21, 2015

  1. Slide 1: DuPont Submission to U.S. FDA: Fast Approaching the Finish Line

    DuPont Submission to U.S. FDA Fast Approaching the Finish Line May 21, 2015

  2. Slide 2: Presenters

    Presenters Karen Polkinghorne Packaging Engineer and MDM Specialist Michael H. Scholla, Ph.D. Global Director, Regulatory and Standards; Medical Packaging Fellow Bruce A. Yost, Ph.D. Global Technical Director 2 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are tradema

  3. Slide 3: The Challenge

    The Challenge A materials science company makes a manufacturing change, impacting a material used in a highly regulated industry. How can this be accomplished without triggering a revalidation? 3 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or register

  4. Slide 4: The Plan

    Plan The Build a matrix of packages, of all shapes and sizes, material combinations & sterilization methods; demonstrate Functional Equivalence between “Transition Protocol material” and “Current material”; work with regulatory bodies around the world; the entire industry leverages the data… 4 Copyr

  5. Slide 5: The Journey

    Journey The Engage numerous global SPMs and MDMs, test labs and regulatory bodies; build packages; generate data; demonstrate Functional Equivalence 5 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and

  6. Slide 6: Functional Equivalence

    Functional Equivalence Prove Functional Equivalence, not statistical equivalence, of 6 line/polymer combinations used in packaging applications for more than 75,000 different end uses 6 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered tradema

  7. Slide 7: U.S. FDA

    U.S.FDA The Oct 18, 2012: We have completed our review of the documentation….we are in agreement with the study design and testing proposed…. FDA will not routinely require Sponsors to amend either their 510(k)s or PMAs In addition, we have worked with regulatory entities from EU, Japan, China and C

  8. Slide 8: Regulatory Report Submission Status as of May 2015

    Regulatory Report Submission Status as of May 2015 8 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/15)

  9. Slide 9: Regulatory News

    Regulatory News Guidance from Intertek has been received and posted to our website Japan minor change notification (Keibi Henko Todoke) We intend to publish ISO 11607 compliance document for Transition Protocol material in June, which industry can reference for their submissions We intend to publish

  10. Slide 10: Helpful Hints

    Helpful Hints After the U.S. FDA issues their guidance, MDMs should place letter(s) in their files before they begin using Transition Protocol material MDMs should not submit information to Health Canada prior to receiving the template from Health Canada Amendments to 510(k)s, PMAs or Health Canada

  11. Slide 11: Sterilization and Ethylene Oxide (EO) Residual Testing

    Sterilization and Ethylene Oxide (EO) Residual Testing The Gurley porosity and MVTR ranges are the same for Current and Transition Protocol materials Are the gases getting into the package during the gaseous sterilization process? Are the gases getting out of the package? EO residual testing was con

  12. Slide 12: Requirements for Interchangeability

    Requirements for Interchangeability Allows MDMs to use either Current Tyvek® or Transition Protocol material interchangeably, provided that: 1) MDM has considered this in their change control, risk management and regulatory submission processes 2) Specifications for the device package do not restric

  13. Slide 13: Considerations

    Considerations Each company has its own change control and risk assessment processes that must be conducted DuPont is providing data and results summaries backed by extensive statistical analysis to determine Functional Equivalence Each company must then decide: 1) How to use this information within

  14. Slide 14: New Reference Library On Our Website

    New Reference Library On Our Website 14 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/15)

  15. Slide 15: The Cell

    The Cell Cell | noun | \’sel\: a validated, commercially available SBS, produced using 3 lots of Transition Protocol material and 3 lots of Current material, sealed at Upper, Lower & Nominal conditions, contains ~1200 to 1500 individual packages 15 Copyright © 2015 DuPont. All rights reserved. The D

  16. Slide 16: Publication of MPTP Test Results in Industry Summary Reports

    Publication of MPTP Test Results in Industry Summary Reports Timing Pre-sterilization and Post-sterilization October 2014 Accelerated Aging (1 Year) February 2015 Accelerated Aging (3, 5 and 7 Years) and Real-time Aging (1 Year) PARTIAL TODAY! Accelerated Aging (3 Years) June 2015 Accelerated Aging

  17. Slide 17: U.S. FDA Transition Protocol Test Matrix — Nelson Laboratories Status

    U.S. FDA Transition Protocol Test Matrix — Nelson Laboratories Testing Status (as of May 13, 2015) 17 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/15)

  18. Slide 18: Phantom Protocol Test Matrix — Nelson Laboratories Status

    Phantom Protocol Test Matrix — Nelson Laboratories Testing Status (as of May 13, 2015) 18 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/15)

  19. Slide 19: MPTP Results after 1-Year Accelerated Aging, Seal Strength

    Industry Summary: MPTP Test Results after 1-Year Accelerated Aging, Pass/Fail Summary for Seal Strength* — ASTM F88 19 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/1

  20. Slide 20: MPTP Interim Results after 3-Year Accelerated Aging

    Industry Summary: MPTP Interim Test Results (75/78 Cells) after 3-Year Accelerated Aging, Pass/Fail Summary for Seal Strength* — ASTM F88 20 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or

  21. Slide 21: MPTP Interim Results after 5-Year Accelerated Aging

    Industry Summary: MPTP Interim Test Results (63/78 Cells) after 5-Year Accelerated Aging, Pass/Fail Summary for Seal Strength* — ASTM F88 21 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or

  22. Slide 22: MPTP Interim Results after 1-Year Real-Time Aging

    Industry Summary: MPTP Interim Test Results (57/78 Cells) after 1-Year Real-Time Aging, Pass/Fail Summary for Seal Strength* — ASTM F88 22 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or i

  23. Slide 23: MPTP Interim Results after 7-Year Accelerated Aging

    Industry Summary: MPTP Interim Test Results (4/11 Cells) after 7-Year Accelerated Aging, Pass/Fail Summary for Seal Strength — ASTM F88 23 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or i

  24. Slide 24: Note on Industry Summary Reports

    Note on Industry Summary Reports Publication error for Pre- and Post-Sterilization and 1-Year Accelerated Aging microbial barrier data in Industry Summary Reports Discovered during generation of Regulatory Summary Reports NO CHANGE IN FUNCTIONAL EQUIVALENCE Conclusion? Transition Protocol material p

  25. Slide 25: The Material

    Material The Referred to as Transition material or Tyvek® Transition Protocol material Tremendous amount of data available for Tyvek® sheet material 25 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and

  26. Slide 26: NEW Transition Protocol Material Data on Our Website

    NEW Transition Protocol Material Data on Our Website Effects of sterilization and 5-year accelerated aging and 1-year real-time aging on: – material puncture strength – material tensile strength – material microbial barrier (ASTM F2638) Effects of sterilization and 5-year accelerated aging on: – cyt

  27. Slide 27: Are You Ready Website

    All of this and more can be found on our website at: www.areyouready.tyvek.com A few helpful hints: • It’s a long list, scroll down • Summary information and reports at the top, followed by technical data, followed by regulatory guidance • As new data and documents are added, we will indicate this w

  28. Slide 28: Are You Ready Website – Regulatory Section

    Are You Ready Website – Regulatory Section 28 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/15)

  29. Slide 29: DuPont 2015 Commercialization Plan

    DuPont 2015 Commercialization Plan May MDMs continue planning with their SPMs and Notified Body(s) June – August MDMs complete their risk assessments, any additional testing and required regulatory notifications (Notified Body for Class III devices, minor change notification in Japan) July DuPont co

  30. Slide 30: The Benefits of Interchangeability

    The Benefits of Interchangeability Functional Equivalence will allow you to accept Current Tyvek® and Transition Protocol material interchangeably U.S. FDA affirmation of Functional Equivalence is expected September 2015 Ensures continuity of supply during the transition period Eliminates the need t

  31. Slide 31: Are You Ready?

    Ready? Are You ü Status of risk assessments and testing ü Controlled sales material ordered ü Class III device(s) sold in EU? ü Engage regulatory & supply chain ü Discuss plans with SPM 31 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered

  32. Slide 32: Bottom Line

    Bottom Line The Data continues to indicate Functional Equivalence U.S. FDA affirmation of Functional Equivalence is expected September 2015 Transition Protocol material interchangeable with Current Tyvek® material following U.S. FDA affirmation of Functional Equivalence 32 Copyright © 2015 DuPont. A

  33. Slide 33: Information

    Information The www.transition.tyvek.com www.areyouready.tyvek.com Global webcasts FAQs Tyvek® Rx Newsletter Live seminars Trade and technical forums Individual meetings 33 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. d

  34. Slide 34: Calendar

    Calendar The June 9: MDM East Lunch and Learn Sept 15: Technical Seminar, Boston, MA Sept 24: Next MPTP Webinar Oct 20: Technical Seminar, Dallas, TX Nov 10: Technical Seminar, East Lansing, MI With additional events around the world. Look for updates from DuPont and our media partners on how to reg

  35. Slide 35: A Note of Appreciation

    A Note of Appreciation Thank you for your business, your continued support and your confidence in DuPont We are committed to support you throughout this transition Together, we can continue to meet the needs of a growing population for safe and sustainable medical packaging www.transition.tyvek.com

  36. Slide 36: Questions?

    Questions? www.transition.tyvek.com www.areyouready.tyvek.com 36 Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. (05/15)

  37. Slide 37: Thank you!

    Thank you! Thank you for attending today’s Webcast: DuPont Submission to U.S. FDA Fast Approaching the Finish Line— Are You Ready? Today’s webcast will be archived for one year for on-demand viewing within this environment. For any additional questions, please contact us: Daphne Allen, Editor, Pharm

  38. Slide 38: Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo, DuPont ™ and

    Copyright © 2015 DuPont. All rights reserved. The DuPont Oval Logo, DuPont™ and Tyvek® are trademarks or registered trademarks of E.I. du Pont de Nemours and Company or its affiliates. 38

DuPont — Technical Presentation (May 2015) on 6ix